2024-09-18 - Analysis Report
##  CL Stock Analysis Report

**Company Overview:** CL, Colgate-Palmolive Company, is a global consumer products company that specializes in oral care, personal care, home care, and pet nutrition products.

**Performance Analysis:**

**1. Rate of Return and Comparison to S&P 500 (VOO):**

* **Cumulative Return:** 57.1%
* **S&P 500 Cumulative Return:** 89.02%
* **Return Difference:** -31.92%
* **Relative Divergence:** 29.17%

This indicates that CL has underperformed the S&P 500, with a 31.92% difference in cumulative returns. However, its relative divergence of 29.17% suggests that this underperformance is within the historical range of its past performance.

**2. Recent Price Action:**

* **Closing Price:** $105.43
* **5-day Moving Average:** $106.09
* **20-day Moving Average:** $105.81
* **60-day Moving Average:** $101.29

The price is currently slightly below the 5-day and 20-day moving averages, indicating potential short-term weakness. However, it is above the 60-day moving average, which could suggest a longer-term upward trend.

**3. Technical Indicators:**

* **RSI:** 52.21
* **PPO:** -0.38
* **Delta_Previous_Relative_Divergence:** 3.46 (Short-term downward trend)
* **Expected Return:** 12.32% (Maximum expected return over 5 years)

The RSI indicates a neutral market sentiment, while the PPO suggests a weakening trend. The negative delta_previous_relative_divergence signals a short-term downward trend.  Despite the negative indicators, the expected return of 12.32% suggests potential future growth.

**4. Recent Earnings and Forecasts:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-26 | 0.89 | 5.06 B$ | 
| 2024-04-26 | 0.83 | 5.07 B$ |
| 2023-10-27 | 0.86 | 4.92 B$ |
| 2023-07-28 | 0.61 | 4.82 B$ |
| 2024-07-26 | 0.61 | 4.82 B$ |

The most recent earnings report for Q2 2024 shows an EPS of $0.89 and revenue of $5.06 billion. The earnings beat analysts' expectations, with an EPS estimate of $0.85. This suggests that CL's revenue continues to grow steadily.

**5. Overall Analysis:**

CL's stock price has underperformed the S&P 500 but is within its historical range. Despite the negative short-term technical indicators, the strong earnings report and positive expected return suggest potential future growth.

**6. Recommendations:**

Given the recent positive earnings, CL might be an attractive long-term investment for investors looking for consistent growth. However, investors should be aware of the short-term downward trend indicated by the technical indicators. Further research and analysis are recommended to assess individual risk tolerance and investment goals.